P03-359 Randomized, double-blind, placebo-controlled study of risperidone long-acting injectable in relapse prevention in patients with bipolar I disorder

2010 ◽  
Vol 25 ◽  
pp. 974 ◽  
Author(s):  
S. Montgomery ◽  
E. Vieta ◽  
A.H. Sulaiman ◽  
R. Cordoba ◽  
B. Huberlant ◽  
...  
Cephalalgia ◽  
1993 ◽  
Vol 13 (2) ◽  
pp. 128-131 ◽  
Author(s):  
Hisham K Al-Qassab ◽  
Leslie J Findley

Thirty patients with severe classical and common migraine participated in a double-blind placebo-con-trolled cross-over study of migraine prophylaxis with propranolol LA (long-acting) 80 mg once daily, or propranolol LA 160 mg once daily or placebo. Each treatment was given for two months. There were no significant differences between the three treatment periods in headache frequency, headache severity, nausea frequency or severity. There was a non-significant trend for reduced duration of headache with the two doses of propranolol. The possible reasons for this negative effect are discussed. The safety of propranolol and its lack of serious side effects were demonstrated.


Pain ◽  
2005 ◽  
Vol 118 (1) ◽  
pp. 92-96 ◽  
Author(s):  
Anna Ambrosini ◽  
Michel Vandenheede ◽  
Paolo Rossi ◽  
Fulvio Aloj ◽  
Enzo Sauli ◽  
...  

Cephalalgia ◽  
1989 ◽  
Vol 9 (10_suppl) ◽  
pp. 367-368 ◽  
Author(s):  
A. Pradalier ◽  
G. Serratrice ◽  
M. Collard ◽  
E. Hirsch ◽  
J. Feve ◽  
...  

PEDIATRICS ◽  
2015 ◽  
Vol 136 (5) ◽  
pp. 885-894 ◽  
Author(s):  
R. L. Findling ◽  
A. Robb ◽  
N. K. McNamara ◽  
M. N. Pavuluri ◽  
V. Kafantaris ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document